Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Author: admin

Press Releases

Vensana Capital Launches with Inaugural $225 Million Fund

Vensana in the News

Podcast: Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana

Portfolio News

Intact Vascular, Vesper Medical Raise Capital to Tackle Blood-Vessel Diseases

Events

Vensana Capital’s Cynthia Yee Keynotes Mayo Clinic and ASU MedTech Accelerator Investor Day: “Developing an ecosystem: strategies for assessing and mitigating risk in medtech investments.“

Vensana in the News

Medical Device Investors Form New Medtech Venture Firm

19

Novel FDA PMA & de novo 510k approvals

45

U.S. Commercial Product Launches

34

Level I Clinical Trials

26

Strategic Financings

28

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial
Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance
Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2022 Vensana Capital Management, LLC | Privacy | Terms & Conditions